Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 13
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Arbaeen AF, Schubert P, Sheffield WP, Devine DV | 2021 | Transfusion | View Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Researchers | New or improved product or process |
ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Arnold DM | 2021 | Blood.ca website | View ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Health care providers | Clinical research |
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Warkentin TE | 2021 | Thromb Haemost | View Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Heather Vander M, Laureano M, Hu G, Lim W, Ross C, Wainman B, Zeller MP | 2021 | Can Med Educ J | View Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Health care providers | Benchmarking and standard setting |
Chaptire 16: Don autologue préopératoire | Foster T, Yan M | 2021 | Guide de la pratique transfusionnelle | View Chaptire 16: Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Chelle P, Hajducek D, Mahdi M, Young S, Iorio A, Silvertown J, Edginton A | 2021 | Res Pract Thromb Haemost | View External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Researchers | New or improved product or process |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM | 2021 | J Thromb Haemost | View Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Five novel FY null alleles associated with typing discrepancies | Vege S, Floch A, Lomas-Frances C, Clarke G, Westhoff CM | 2021 | Transfusion | View Five novel FY null alleles associated with typing discrepancies | Researchers | Benchmarking and standard setting |
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC | 2021 | BMJ Open | View Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Researchers | Clinical research |
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Khan H, Jain S, Gallant RC, Syed MH, Zamzam A, Al-Omran M, Rand ML, Ni H, Abdin R, Qadura M | 2021 | J Pers Med | View Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Researchers | New or improved product or process |
Chapter 2: Blood components | Gupta A, Bigham M | 2021 | Clinical Guide to Transfusion | View Chapter 2: Blood components | Health care providers | Benchmarking and standard setting |
Prevention of transfusion-transmitted syphilis by blood operators: How much is enough when transfusion-transmission has not been identified for decades? | Drews SJ | 2021 | Transfusion | View Prevention of transfusion-transmitted syphilis by blood operators: How much is enough when transfusion-transmission has not been identified for decades? | Blood operators | Benchmarking and standard setting |
Déclaration des réactions transfusionnelles indésirables | Yan M | 2021 | Blood.ca website | View Déclaration des réactions transfusionnelles indésirables | Health care providers | Benchmarking and standard setting |
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B | Sun HL, Yang M, Poon MC, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Res Pract Thromb Haemost | View The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B | Researchers | Clinical research |
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Cook O, Cervi A, Laureano M, Gangji AS, Verhovsek M | 2021 | Transfus Apher Sci | View Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Researchers | Clinical research |
Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Batarfi K | 2021 | Blood.ca website | View Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Researchers | Clinical research |
Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? | Cruz-Leal Y, Lazarus AH | 2021 | Transfusion | View Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? | Researchers | Basic research |
Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US | Holloway K, Miller FA, Simms N | 2021 | Soc Sci Med | View Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US | Researchers | Ethical, legal and social implications research |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Stewart T | 2021 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Health care providers | Benchmarking and standard setting |
Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Laureano M, Mithoowani S, Tseng E, Zeller M | 2021 | Adv Med Educ Pract | View Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Health care providers | Benchmarking and standard setting |
Chapter 16: Preoperative autologous donation | Foster T, Yan M | 2021 | Clinical Guide to Transfusion | View Chapter 16: Preoperative autologous donation | Health care providers | Benchmarking and standard setting |
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine | Chan BT, Bobos P, Odutayo A, Pai M | 2021 | medRxiv | View Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine | Researchers | Clinical research |
The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Alshalani A, van Manen L, Boshuizen M, van Bruggen R, Acker JP, Juffermans NP | 2021 | Transfus Med Hemotherapy | View The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Researchers | Clinical research |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Li N, Chiang F, Down DG, Heddle NM | 2021 | Oper Res Health Care | View A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Health care providers | New or improved product or process |
Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Branch DR, Holton MB, Ison T, Cote J, Dube C, Lau W | 2021 | Transfusion | View Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Researchers | Basic research |
Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I | 2021 | Am J Hematol | View Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Researchers | Clinical research |
Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Vardaki MZ, Schulze HG, Serrano K, Blades MW, Devine DV, Turner RFB | 2021 | Transfusion | View Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Researchers | New or improved product or process |
Lessons from vaccine-induced immune thrombotic thrombocytopenia | Kelton JG, Arnold DM, Nazy I | 2021 | Nat Rev Immunol | View Lessons from vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Guide de la pratique transfusionnelle | View Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
Themed issue – focusing on donor assessment, motivation and vigilance | O’Brien SF, Ullum H, Seed CR | 2021 | Vox Sang | View Themed issue – focusing on donor assessment, motivation and vigilance | Researchers | New or improved product or process |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Haemophilia | View Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Researchers | Clinical research |
Challenging the 30-min rule for thawed plasma | Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W | 2021 | Vox Sang | View Challenging the 30-min rule for thawed plasma | Researchers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
How do I think about blood donor eligibility criteria for medical conditions? | Goldman M | 2021 | Transfusion | View How do I think about blood donor eligibility criteria for medical conditions? | Researchers | Benchmarking and standard setting |
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Batarfi K | 2021 | Blood.ca website | View ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Researchers | Clinical research |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |